ArticleBiomarker research2016

The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines.

Linn Reinholdt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.